About the Company
igc is developing a product portfolio of phytocannabinoid-based therapies through leading edge research for the treatment of a wide range of therapeutic indications. these include neuropathic and cancer pain, epilepsy, end of life supportive care, adjunctive supportive therapies of chronic neurological and oncological diagnosis, which are life altering or life threatening our mission is to treat pain, ptsd, seizures, cachexia, chronic and terminal neurological and oncological diagnoses, and other life altering conditions with phytocannabinoid-based treatments
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $IGC News
IGC Pharma Announces Q3 2024 Earnings: Strategic Patent Achievements Propel Forward Amid Losses
IGC Pharma Inc (AMEX:IGC), a pharmaceutical company based in Maryland, announced its financial results for the third quarter of fiscal year 2024 ending December 31st, 2023. The period was marked by ...
IGC Pharma (IGC): Healthcare Leader Terry Lierman Joins Board to Advance Alzheimer's Pipeline
IGC Pharma, Inc. (“IGC Pharma,” “IGC,” or the “Company”) (NYSE American: IGC) today announced that it has appointed Terry Lierman as ...
Investornewsbreaks - IGC Pharma Inc. (NYSE American: IGC) Names Healthcare Leader To Board Of Directors
To view the full press release, visit IGC Pharma Inc. is at the forefront of the fight against Alzheimer's disease, developing innovative solutions to address this devastating illness. The company's ...
IGC Pharma Announces TGR-63 Reduces Agitation in Alzheimer's Mouse Model
IGC Pharma, Inc. ("IGC Pharma," "IGC," or the "Company") (NYSE American: IGC) today announced additional positive results of preclinical studies investigating the Company's newly announced therapeutic ...
Investornewsbreaks - IGC Pharma Inc. (NYSE American: IGC) Spotlighted In Ascendiant Equity Analyst Report
(MENAFN- Investor Brand Network) IGC Pharma (NYSE American: IGC) , a clinical-stage pharmaceutical company, is featured in a recent analyst coverage research report issued by Ascendiant Capital ...
IGC Pharma (IGC): Healthcare Leader Terry Lierman Joins Board to Advance Alzheimer’s Pipeline
IGC Pharma, Inc. (“IGC Pharma,” “IGC,” or the “Company”) (NYSE American: IGC) today announced that it has appointed Terry Lierman as an independent director to its board of directors.
IGC Pharma Inc IGC
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
IGC Pharma Announces TGR-63 Reduces Agitation in Alzheimer's Mouse Model
IGC Pharma, Inc. ("IGC Pharma," "IGC," or the "Company") (NYSE American: IGC) today announced additional positive results of preclinical studies investigating the Company's newly announced ...
IGC Pharma (IGC): Healthcare Leader Terry Lierman Joins Board to Advance Alzheimer’s Pipeline
IGC Pharma, Inc. (“IGC Pharma,” “IGC,” or the “Company”) (NYSE American: IGC) today announced that it has appointed ...
Loading the latest forecasts...